Verrucous squamous cell carcinoma arising in necrobiosis lipoidica in a young woman
Necrobiosis lipoidica (NL) is a chronic granulomatous degenerative disease, presenting clinically as yellow-brown plaques with central atrophy and elevated violaceous borders.1,2 The condition shows a 3:1 female-to-male ratio and most commonly affects the pretibial region.1,3 NL is classically associated with diabetes mellitus, accounting for 11% to 85% of NL cases, with onset typically in the third decade for type 1 and the fourth decade for type 2 diabetes.3,4 Despite this association, the incidence of NL among individuals with diabetes is low, affecting only 0.3% to 1.2% of this population.
Authors
- Jesse W. Currier (ORCID: https://orcid.org/0000-0001-5548-5154)
- Bryan Daines
- George J. Murakawa
- Jeremy A. Grekin
- Chiara Rosenbaum
Institutions
- Central Michigan University (US)
- Oakland University (US)
- Beaumont Health (US)
- Royal Oak Community Coalition (US)
- Beaumont Hospital (US)
- Somerset Skin Centre (US)
- Michigan State University (US)
Publication Details
- Journal
- JAAD Case Reports
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1016/j.jdcr.2025.03.007
- Primary Topic
- Skin Diseases and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Pfizer
- Astellas Pharma US
- Sanofi
- Regeneron Pharmaceuticals
- Valeant Pharmaceuticals International
- Kiniksa Pharmaceuticals
- Incyte
- Castle Biosciences
- Astellas Pharma
- Galderma
- Sanofi Genzyme
- Janssen Pharmaceuticals